Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease
Ruwani Wijeyekoon(Wellcome/MRC Cambridge Stem Cell Institute), Caroline H. Williams‐Gray(University of Cambridge)
Cited by 112
Related Papers
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
|The Lancet Neurology|2017|189
The role of high‐field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward
|Movement Disorders|2017|119
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease
|Brain|2021|97
Locus Coeruleus Integrity from <scp>7 T MRI</scp> Relates to Apathy and Cognition in Parkinsonian Disorders
|Movement Disorders|2022|66
Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes
|PLoS Computational Biology|2022|51